Molekulargenetisches Labor
Zentrum für Nephrologie und Stoffwechsel

7-Dehydrocholesterol-Reductase

Das DHCR7-Gen kodiert ein transmembranöses Enzym der Cholesterin-Synthese. Mutationen führen zu autosomal rezessivem Smith-Lemli-Opitz-Syndrom, welches durch einen niederigen Serumcholesterinspiegel charakterisiert ist.

Gentests:

Klinisch Untersuchungsmethoden Familienuntersuchung
Bearbeitungszeit 5 Tage
Probentyp genomische DNS
Klinisch Untersuchungsmethoden Hochdurchsatz-Sequenzierung
Bearbeitungszeit 25 Tage
Probentyp genomische DNS
Forschung Untersuchungsmethoden Direkte Sequenzierung der proteinkodierenden Bereiche eines Gens
Bearbeitungszeit 25 Tage
Probentyp genomische DNS

Verknüpfte Erkrankungen:

Smith-Lemli-Opitz-Syndrom
DHCR7

Referenzen:

1.

Porter JA et al. (1996) Cholesterol modification of hedgehog signaling proteins in animal development.

[^]
2.

Shefer S et al. (1995) Markedly inhibited 7-dehydrocholesterol-delta 7-reductase activity in liver microsomes from Smith-Lemli-Opitz homozygotes.

[^]
3.

Wassif CA et al. (1998) Mutations in the human sterol delta7-reductase gene at 11q12-13 cause Smith-Lemli-Opitz syndrome.

[^]
4.

Fitzky BU et al. (1998) Mutations in the Delta7-sterol reductase gene in patients with the Smith-Lemli-Opitz syndrome.

[^]
5.

Nowaczyk MJ et al. (1998) Smith-Lemli-Opitz syndrome: phenotypic extreme with minimal clinical findings.

[^]
6.

Yu H et al. (2000) Detection of a common mutation in the RSH or Smith-Lemli-Opitz syndrome by a PCR-RFLP assay: IVS8-G-->C is found in over sixty percent of US propositi.

[^]
7.

Yu H et al. (2000) Spectrum of Delta(7)-dehydrocholesterol reductase mutations in patients with the Smith-Lemli-Opitz (RSH) syndrome.

[^]
8.

Witsch-Baumgartner M et al. (2001) Frequency gradients of DHCR7 mutations in patients with Smith-Lemli-Opitz syndrome in Europe: evidence for different origins of common mutations.

[^]
9.

Wassif CA et al. (2001) Biochemical, phenotypic and neurophysiological characterization of a genetic mouse model of RSH/SmithLemliOpitz syndrome.

[^]
10.

Nowaczyk MJ et al. (2001) DHCR7 genotypes of cousins with Smith-Lemli-Opitz syndrome.

[^]
11.

Nowaczyk MJ et al. (2001) Smith-Lemli-Opitz (RHS) syndrome: holoprosencephaly and homozygous IVS8-1G-->C genotype.

[^]
12.

Langius FA et al. (2003) Identification of three patients with a very mild form of Smith-Lemli-Opitz syndrome.

[^]
13.

Kovarova M et al. (2006) Cholesterol deficiency in a mouse model of Smith-Lemli-Opitz syndrome reveals increased mast cell responsiveness.

[^]
14.

Witsch-Baumgartner M et al. (2008) Age and origin of major Smith-Lemli-Opitz syndrome (SLOS) mutations in European populations.

[^]
15.

Koo G et al. (2010) Discordant phenotype and sterol biochemistry in Smith-Lemli-Opitz syndrome.

[^]
16.

Kalb S et al. (2012) High frequency of p.Thr93Met in Smith-Lemli-Opitz syndrome patients in Turkey.

[^]
17.

Moebius FF et al. (1998) Molecular cloning and expression of the human delta7-sterol reductase.

[^]
18.

Waterham HR et al. (1998) Smith-Lemli-Opitz syndrome is caused by mutations in the 7-dehydrocholesterol reductase gene.

[^]
19.

De Brasi D et al. (1999) Smith-Lemli-Opitz syndrome: evidence of T93M as a common mutation of delta7-sterol reductase in Italy and report of three novel mutations.

[^]
20.

Witsch-Baumgartner M et al. (2000) Mutational spectrum in the Delta7-sterol reductase gene and genotype-phenotype correlation in 84 patients with Smith-Lemli-Opitz syndrome.

[^]
21.

Kelley RI et al. (2000) The Smith-Lemli-Opitz syndrome.

[^]
22.

Krakowiak PA et al. (2000) Mutation analysis and description of sixteen RSH/Smith-Lemli-Opitz syndrome patients: polymerase chain reaction-based assays to simplify genotyping.

[^]
23.

Löffler J et al. (2000) Homozygosity for the W151X stop mutation in the delta7-sterol reductase gene (DHCR7) causing a lethal form of Smith-Lemli-Opitz syndrome: retrospective molecular diagnosis.

[^]
24.

Prasad C et al. (2002) Smith-Lemli-Opitz syndrome: new mutation with a mild phenotype.

[^]
25.

Opitz JM et al. () Cholesterol and development: the RSH ("Smith-Lemli-Opitz") syndrome and related conditions.

[^]
26.

Wright BS et al. (2003) Carrier frequency of the RSH/Smith-Lemli-Opitz IVS8-1G>C mutation in African Americans.

[^]
27.

Mueller C et al. (2003) Normal cognition and behavior in a Smith-Lemli-Opitz syndrome patient who presented with Hirschsprung disease.

[^]
28.

Ciara E et al. (2004) DHCR7 mutations and genotype-phenotype correlation in 37 Polish patients with Smith-Lemli-Opitz syndrome.

[^]
29.

Scalco FB et al. (2005) DHCR7 mutations in Brazilian Smith-Lemli-Opitz syndrome patients.

[^]
30.

Matsumoto Y et al. (2005) R352Q mutation of the DHCR7 gene is common among Japanese Smith-Lemli-Opitz syndrome patients.

[^]
31.

Nowaczyk MJ et al. (2006) DHCR7 mutation carrier rates and prevalence of the RSH/Smith-Lemli-Opitz syndrome: where are the patients?

[^]
32.

NCBI article

NCBI 1717 [^]
33.

OMIM.ORG article

Omim 602858 [^]
34.

Orphanet article

Orphanet ID 121066 [^]
35.

Wikipedia Artikel

Wikipedia DE (7-Dehydrocholesterol-Reduktase) [^]
Update: 29. April 2019